NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
-0.28%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$7.68B
AUM Growth
+$7.68B
(+72%)
Cap. Flow
+$3.58B
Cap. Flow
% of AUM
46.59%
Top 10 Holdings %
Top 10 Hldgs %
77.12%
Holding
65
New
7
Increased
1
Reduced
7
Closed
2
Top Buys
| 1 |
NeueHealth
NEUE
|
$3.74B |
| 2 |
Monte Rosa Therapeutics
GLUE
|
$175M |
| 3 |
BILL Holdings
BILL
|
$103M |
| 4 |
CVRx
CVRX
|
$66.4M |
| 5 |
OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
|
$44.7M |
Top Sells
| 1 |
Coursera
COUR
|
$180M |
| 2 |
DM
Desktop Metal, Inc.
DM
|
$104M |
| 3 |
Sprout Social
SPT
|
$89.2M |
| 4 |
EAR
Eargo, Inc. Common Stock
EAR
|
$79.8M |
| 5 |
Opendoor
OPEN
|
$59.1M |
Sector Composition
| 1 | Healthcare | 79.17% |
| 2 | Consumer Staples | 8.56% |
| 3 | Technology | 5.15% |
| 4 | Industrials | 3.37% |
| 5 | Financials | 1.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeueHealth
NEUE
$59.2M
| $3.74B | 48.77% | +218,212,128 | New | +$3.74B |
|
|
2
Coursera
COUR
$1.88B
| $657M | 8.56% | 16,603,063 -4,553,828 | -22% | -$180M |
|
3
Cloudflare
NET
$72.7B
| $292M | 3.81% | 2,763,583 | – | – |
|
4
CRISPR Therapeutics
CRSP
$4.71B
| $257M | 3.35% | 1,590,002 | – | – |
|
|
DM
5
DELISTED
Desktop Metal, Inc.
DM
| $223M | 2.91% | 19,410,631 -9,005,457 | -32% | -$104M |
|
|
ALLK
6
DELISTED
Allakos
ALLK
| $185M | 2.41% | 2,164,704 | – | – |
|
|
EAR
7
DELISTED
Eargo, Inc. Common Stock
EAR
| $180M | 2.35% | 4,520,670 -2,000,278 | -31% | -$79.8M |
|
|
8
Monte Rosa Therapeutics
GLUE
$296M
| $175M | 2.28% | +7,703,205 | New | +$175M |
|
9
Ardelyx
ARDX
$1.53B
| $103M | 1.35% | 13,633,582 | – | – |
|
|
10
BILL Holdings
BILL
$4.72B
| $103M | 1.34% | +560,774 | New | +$103M |
|
|
OYST
11
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $102M | 1.33% | 5,925,287 | – | – |
|
12
Rhythm Pharmaceuticals
RYTM
$6.85B
| $96.2M | 1.25% | 4,912,306 | – | – |
|
13
Nkarta
NKTX
$151M
| $92.1M | 1.2% | 2,904,974 | – | – |
|
|
MILE
14
DELISTED
Metromile, Inc. Common Stock
MILE
| $85.9M | 1.12% | 9,384,295 | – | – |
|
|
ADAP
15
Adaptimmune Therapeutics
ADAP
$15.6M
| $72.8M | 0.95% | 17,082,611 | – | – |
|
16
Mirum Pharmaceuticals
MIRM
$3.71B
| $72.4M | 0.94% | 4,187,801 | – | – |
|
17
Aurinia Pharmaceuticals
AUPH
$1.58B
| $67M | 0.87% | 5,172,683 | – | – |
|
|
18
CVRx
CVRX
$205M
| $66.4M | 0.86% | +2,370,858 | New | +$66.4M |
|
|
19
Opendoor
OPEN
$3.27B
| $59.1M | 0.77% | 3,333,276 -3,333,272 | -50% | -$59.1M |
|
20
Annexon
ANNX
$226M
| $56.2M | 0.73% | 2,497,661 | – | – |
|
|
TRIL
21
DELISTED
Trillium Therapeutics Inc.
TRIL
| $55.6M | 0.72% | 5,736,363 | – | – |
|
|
AKUS
22
DELISTED
Akouos, Inc. Common Stock
AKUS
| $53.9M | 0.7% | 4,298,488 | – | – |
|
23
VistaGen Therapeutics
VTGN
$102M
| $51.4M | 0.67% | 16,302,596 | – | – |
|
|
CSPR
24
DELISTED
Casper Sleep Inc.
CSPR
| $51.3M | 0.67% | 6,226,130 | – | – |
|
|
OKUR
25
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $44.7M | 0.58% | +4,786,921 | New | +$44.7M |
|